Replies to post #58857 on Sigma Labs Inc (SASI)

[Pisd]

Great DD. Honest don't you think this was a material event?

Also, surely how do long term supporters/owners of Sigma stock get their head around this?

Response from Bret.

Good Afternoon .

Sigma and M3D are strategic partners. They no longer have a PR3D at M3D due to Autumn 2017 decision that they cannot support R&D installations given their current end-user demonstration load. Sigma is now working on participating with M3D in the Innovation Center that M3d plans to open. The Innovation Centert was delayed by M3D’s immersion in their recent refinancing

Hope this helps.

Bret


Bret Shapiro |Managing Partner
CoreIR
377 Oak Street -Concourse 2-Garden City , NY 11530
1-561-479-8566 - Cell |bret.shapiro2-Skype
[e-mail]|www.coreir.com

Best wishes, and thanks for reporting back the response...

[RiskReward1]

This is pure CEO applying business smarts sort of move, in my view. Before I had heard the explanation about commercial sales focus vs R&D I had read into Morph's not having the latest PR3D that Rice would have wanted Medeira to pay for it. It looked to me -- and continues to -- that Rice wants to hold out the value of PR3D from Morf until whatever potential deal that may be struck is struck, so that Sigma gets the most attractive terms possible, should a deal involving Sigma come together. To park the product with Morf, particularly the latest version, and then wait to see what place there may be in a possible future deal with Morf, and at what cost/contribution Morf invites Sigma to participate, might be a CTO move, but it wouldn't be a CEO move.

Thanks, Z.